Hearing Loss: Clinical Trials

1,366 trials for Hearing Loss, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

692 completed, 198 unknown, 184 recruiting, 93 not yet recruiting. 805 Not applicable, 108 Phase 2, 60 Phase 1, 36 Phase 3, 17 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable805Completed 451, Recruiting 102, Unknown 94, Not yet recruiting 44, Terminated 36, Withdrawn 35, Active not recruiting 23, Enrolling by invitation 18, Suspended 2
Phase 2108Completed 46, Recruiting 16, Unknown 12, Not yet recruiting 10, Terminated 10, Active not recruiting 6, Withdrawn 6, Enrolling by invitation 1, Suspended 1
Phase 160Completed 26, Recruiting 10, Unknown 7, Not yet recruiting 5, Terminated 5, Withdrawn 4, Active not recruiting 2, Suspended 1
Phase 336Completed 10, Terminated 7, Not yet recruiting 5, Unknown 5, Recruiting 4, Active not recruiting 3, Suspended 1, Withdrawn 1
Phase 417Completed 6, Unknown 4, Recruiting 3, Withdrawn 2, Not yet recruiting 1, Terminated 1
Early Phase 112Completed 5, Recruiting 2, Unknown 2, Enrolling by invitation 1, Not yet recruiting 1, Terminated 1

Follow Hearing Loss: new trials by email Literature Review of Hearing Loss trials Research Report on Hearing Loss

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant
Otic neural progenitors, cochlear implantation - Sensorineural Hearing Loss, Presbyacusis
Phase 1 / Phase 2Not yet recruitingRinri Therapeutics202027-09-012026-10-01
Hearing Loss and Brain Health Study
Over-The-Counter (OTC) hearing aid - Hearing Loss, Adult-Onset, Dementia
Not applicableNot yet recruitingUniversity of Southern California402027-07-012026-05-08
Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE)
The Microtable® Stereotactic System - Hearing Loss, Cochlear
Not applicableNot yet recruitingMedical University of South Carolina122027-07-012026-06-18
Cochlear Implantation and Social Outcomes
Cochlear implant - Hearing Loss, Bilateral Sensorineural
Not yet recruitingUniversity of Southern California402027-07-012026-06-22
Intervention for Hearing Health Among Native Americans
Talking Circle, Diabetes prevention program & delayed TC - Noise-Induced Hearing Loss
Not applicableNot yet recruitingUniversity of California, San Francisco4002027-04-012026-08-21
Maximizing Quality of Life After Cancer Through Rehabilitation
TIMELY REHAB - Head and Neck Cancer, Hearing Loss
Not applicableNot yet recruitingVA Office of Research and Development742027-03-012026-06-03
From Early Music Audiometry to Tone Audiograms
Soundfield Behavioral Audiometry - Hearing Loss, Audiometric Tests
Not yet recruitingGuy's and St Thomas' NHS Foundation Trust1002027-03-012026-07-24
A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
Glycerol Tributyrate - MELAS Syndrome, Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus)
Phase 1 / Phase 2Not yet recruitingGeorge Washington University242027-03-012026-10-05
Effect of a Totally Implantable Cochlear Implant on Tinnitus Severity in Adults With Preoperative Tinnitus
Cochlear implant - Sensorineural Hearing Loss, Tinnitus
Not applicableNot yet recruitingCochlear142027-02-012026-10-26
Auditory-Cognitive Optimization Care Program for Older Adults With Hearing Loss and Cognitive Impairment
Auditory-Cognitive Optimization Care Program (A-COP), Hearing Management and Newspaper-Reading Activities - Hearing Loss, Cognitive Impairment
Not applicableNot yet recruitingTaipei Medical University762027-02-012026-10-13
A Study Testing the Safety and Possible Benefits of an Ear Injection of a New Compound, Paliroden, in People With Type 2 Diabetes Who Have Difficulty Understanding Speech in Noisy Situations
CIL001 (Paliroden), Placebo - Cochlear Synaptopathy
Phase 1 / Phase 2Not yet recruitingCilcare SAS1352027-01-012026-10-26
A Study Testing Safety and Efficacy of Transtympanic Paliroden for the Treatment of Cochlear Synaptopathy in Participants With Chronic, Constant Tinnitus
paliroden (CIL001), Placebo - Tinnitus, Bilateral, Cochlear Synaptopathy
Phase 1 / Phase 2Not yet recruitingCilcare SAS602027-01-012026-09-17
The Hear Clear Study
Signal-to-Noise Ratio Enhancement (SNR+), Signal-to-Noise Ratio Neutral (SNR-) - Hearing Loss
Not applicableNot yet recruitingDuke University1252027-01-012026-09-21
Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss
Dexamethasone, Hyaluronic acid, Indocyanine green(ICG) - Hearing Loss, Sensorineural, Hearing Loss, Sudden
Phase 1 / Phase 2WithdrawnSeoul National University Hospital2026-12-152026-05-22
24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome
N-acetylcysteine amide, Placebo - Retinitis Pigmentosa (RP), Usher Syndrome
Phase 3Not yet recruitingNacuity Pharmaceuticals, Inc.802026-12-012026-07-01
SPI-1005 in Adults Receiving Cochlear Implant
Ebselen, Placebo - Hearing Loss, Cochlear Trauma
Phase 2RecruitingSound Pharmaceuticals, Incorporated402026-12-012026-06-26
A Study to Evaluate Clinical Benefit, Performance and Safety of Cochlear Implants in Adults
Cochlear Nucleus Nexa Cochlear implant (CI1032), Cochlear Nucleus Nexa Cochlear implant (CI1022), Cochlear Nucleus Nexa Cochlear implant (CI1012) - Hearing Loss, Hearing Implants
Not yet recruitingCochlear662026-12-012026-10-22
HEARS Maryland: Extending Capacity for Affordable, Accessible Hearing Care Through Older Adult Peer Mentorship
HEARS MD Device, HEARS MD Program - Hearing Loss, Hearing Impairment
Not applicableNot yet recruitingJohns Hopkins University3002026-11-302026-07-29
Outcomes of Cartilage Tympanoplasty in Children
Cartilage Tympanoplasty - Tympanic Membrane Perforation, Conductive Hearing Loss
Not applicableNot yet recruitingAssiut University352026-11-012026-10-08
Post-Market Registry Study for Vibrant Hearing Solutions
Conductive Hearing Loss, Mixed Hearing Loss
Enrolling by invitationMED-EL Elektromedizinische Geräte GmbH502026-10-262026-10-30

Showing 20 of 1366. Sign in to see all of them.

Narrower conditions

Hearing Loss, Sensorineural (339)  ·  Deafness (148)  ·  Hearing Loss, Conductive (82)  ·  Presbycusis (66)  ·  Tinnitus (66)  ·  Hearing Loss, Sudden (65)  ·  Hearing Loss, Bilateral (54)  ·  Hearing Loss, Unilateral (49)  ·  Hearing Loss, Noise-Induced (45)  ·  Hearing Loss, Mixed Conductive-Sensorineural (44)  ·  Hearing Disorders (39)  ·  Usher Syndromes (33)  ·  Cognitive Dysfunction (32)  ·  Retinitis Pigmentosa (27)

Broader conditions

Nervous System Diseases (1363)  ·  Neurologic Manifestations (1362)  ·  Sensation Disorders (1362)  ·  Pathological Conditions, Signs and Symptoms (1357)  ·  Signs and Symptoms (1355)  ·  Otorhinolaryngologic Diseases (1350)  ·  Ear Diseases (1345)  ·  Hearing Disorders (1327)  ·  Hearing Loss, Sensorineural (125)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (81)  ·  Eye Diseases (73)  ·  Mental Disorders (73)  ·  Behavior (71)  ·  Congenital Abnormalities (64)

Interventions

Hearing Aids (74)  ·  Cochlear Implants (43)  ·  Cochlear Implantation (20)  ·  Audiometry (11)  ·  Dexamethasone (11)  ·  ebselen (11)  ·  Hearing (10)  ·  Acetylcysteine (9)  ·  Noise (9)  ·  Methylprednisolone (8)  ·  Surveys and Questionnaires (8)  ·  Standard of Care (6)  ·  Audiometry, Pure-Tone (5)  ·  Blood Specimen Collection (5)  ·  Exercise (5)

Sponsors

Cochlear (84)  ·  Sonova AG (80)  ·  Oticon Medical (42)  ·  MED-EL Elektromedizinische Geräte GesmbH (24)  ·  Assistance Publique - Hôpitaux de Paris (21)  ·  US Department of Veterans Affairs (18)  ·  VA Office of Research and Development (18)  ·  Med-El Corporation (16)  ·  Northwestern University (16)  ·  NYU Langone Health (15)  ·  Washington University School of Medicine (15)  ·  University Hospital, Toulouse (14)  ·  Assiut University (12)  ·  Hospices Civils de Lyon (12)  ·  National Institute on Deafness and Other Communication Disorders (NIDCD) (11)

Countries

United States (517)  ·  France (144)  ·  United Kingdom (77)  ·  Switzerland (66)  ·  Canada (64)  ·  Australia (61)  ·  Germany (60)  ·  Belgium (48)  ·  China (44)  ·  Netherlands (40)  ·  Turkey (Türkiye) (30)  ·  Denmark (26)  ·  Sweden (26)  ·  Spain (24)  ·  Israel (20)

Top investigators

Jinyu Qian, PhD (9)  ·  Carl LeBel, PhD (7)  ·  Jonathan Kil, MD (6)  ·  Barbara Simon, AuD (5)  ·  Bart Volckaerts, PhD (5)  ·  Juliane Raether (5)  ·  Pamela Souza, PhD (4)  ·  Thomas B Friedman, Ph.D. (4)  ·  Yu-Hsiang Wu, PhD (4)  ·  Bruce J Gantz, MD (3)  ·  Gabrielle H Saunders (3)  ·  Hillary Snapp, AuD (3)  ·  Jill B Firszt, PhD (3)  ·  Joshua M Levy, M.D. (3)  ·  Kevin Seitz-Paquette, AuD (3)

Results publications

PMID 35724253, PMID 17030153, PMID 24975234, PMID 25133431, PMID 29330858, PMID 30300158, PMID 32483557, PMID 35386404, PMID 35998103, PMID 36907833, PMID 37287104, PMID 37318215, PMID 37552281, PMID 41059917, PMID 41085057, PMID 10459293, PMID 10547481, PMID 10590970, PMID 11074842, PMID 11283492, PMID 11587599, PMID 11893444, PMID 12467365, PMID 12467367, PMID 12697801, PMID 12697802, PMID 12809326, PMID 12851547, PMID 14518792, PMID 14576249, PMID 15064663, PMID 15189754, PMID 15341225, PMID 1555319, PMID 15715067, PMID 15978485, PMID 16244757, PMID 16244758, PMID 16244759, PMID 16504089, PMID 16640056, PMID 17069317, PMID 17200216, PMID 17204902, PMID 17240287, PMID 17329129, PMID 17450108, PMID 17453456, PMID 17910555, PMID 17943685

NIH funding

R01DC015997 (4), 2023 (3), 2018 (2), K23DC022303 (2), R01DC012289 (2), R01DC020194 (2), R01DC021980 (2), R33DC011827 (2), U01HG006487 (2), 1RC1LM010526 (1), 1UG1EY033293 (1), 2009 (1), 2015 (1), 2016 (1), 2017 (1)